CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 42 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $7,000 | -12.5% | 21,000 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | +14.3% | 21,000 | -4.5% | 0.00% | – |
Q3 2019 | $7,000 | +16.7% | 22,000 | 0.0% | 0.00% | – |
Q2 2019 | $6,000 | -75.0% | 22,000 | 0.0% | 0.00% | – |
Q1 2019 | $24,000 | -36.8% | 22,000 | 0.0% | 0.00% | – |
Q4 2018 | $38,000 | +2.7% | 22,000 | +238.5% | 0.00% | – |
Q2 2017 | $37,000 | +5.7% | 6,500 | +8.3% | 0.00% | – |
Q1 2017 | $35,000 | +34.6% | 6,000 | +20.0% | 0.00% | – |
Q4 2016 | $26,000 | +160.0% | 5,000 | 0.0% | 0.00% | – |
Q3 2016 | $10,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
Q2 2016 | $10,000 | -9.1% | 5,000 | 0.0% | 0.00% | – |
Q1 2016 | $11,000 | -21.4% | 5,000 | 0.0% | 0.00% | – |
Q4 2015 | $14,000 | +250.0% | 5,000 | +400.0% | 0.00% | – |
Q3 2015 | $4,000 | -42.9% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2014 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
Q3 2014 | $6,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2014 | $9,000 | +12.5% | 1,000 | 0.0% | 0.00% | – |
Q1 2014 | $8,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,192,080 | $6,282,000 | 2.96% |
COURAGE CAPITAL MANAGEMENT LLC | 100,000 | $527,000 | 0.33% |
Crawford Lake Capital Management, LLC | 69,100 | $364,000 | 0.26% |
Hall Kathryn A. | 31,355 | $166,000 | 0.20% |
ELLINGTON MANAGEMENT GROUP LLC | 29,300 | $154,000 | 0.02% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $116,000 | 0.02% |
Virtu KCG Holdings LLC | 150,357 | $792,000 | 0.02% |
THOMPSON DAVIS & CO., INC. | 2,000 | $11,000 | 0.02% |
Jasper Ridge Partners, L.P. | 47,481 | $250,000 | 0.02% |
AXA S.A. | 479,686 | $2,528,000 | 0.01% |